PPAR ResearchVolume 2012 (2012), Article ID 814945, 6 pagesdoi:10.1155/2012/814945

Review Article

PPARα as a Transcriptional Regulator for Detoxification of Plant Diet-Derived Unfavorable Compounds

Bunichiro Ashibe,1,2 Yu Nakajima,¹ Yuka Fukui,¹ and Kiyoto Motojima¹

¹Department of Biochemistry, Meiji Pharmaceutical University, 2-522-1 Kiyose, Tokyo 204-8588, Japan²Central Research Center, Yomeishu Seizo Co., Ltd., Minowa, Nagano 399-4601, Japan

Received 18 December 2011; Revised 5 February 2012; Accepted 26 February 2012

Academic Editor: Annamaria Cimini

Copyright © 2012 Bunichiro Ashibe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Plants contain potentially toxic compounds for animals and animals have developed physiological strategies to detoxify the ingested toxins during evolution. Feeding mice with various plant seeds and grains showed unexpected result that only sesame killed PPARα-null mice but not wild-type mice at all. A detailed analysis of this observation revealed that PPARα is involved in the metabolism of toxic compounds from plants as well as endobiotic substrates by inducing phase I and phase II detoxification enzymes. PPARα plays a vital role in direct or indirect activation of the relevant genes via the complex network among other xenobiotic nuclear receptors. Thus, PPARα plays its wider and more extensive role in energy metabolism from natural food intake to fat storage than previously thought.

1. Introduction

Animals feed on plants for nutritional and tasting reasons. Plants and seeds are important energy sources but they also contain unique compounds and a variety of secondary metabolites some of which are potentially toxic to animals [1]. Chlorophyll, for example, is a green pigment essential for conversion of the energy of sunlight into chemical energy but its derivative contains a branched fatty acid, phytanic acid, which is toxic at least for rodents and human. Popular plant toxins include flavonoids, isoflavonoids, and tannins, but there should be much more. Animals have developed physiological strategies to avoid specific plants and to detoxify the ingested toxins. Physiological detoxification can occur in the mouth and the gut rumen with or without a help of microbes and once absorbed toxins must be detoxified in the intestine and liver [2]. Phytanic acid is completely broken down in the liver and a fatty aldehyde dehydrogenase, FALDH encoded by ALDH3A2, plays a key role in the process [3–5] as its defect causes Sjögren-Larsson syndrome [6, 7]. However, identification of potentially toxic compounds in plants and seeds is incomplete and the mechanisms of detoxification steps have not been well characterized yet because most animal studies to date have been carried out using artificial laboratory diets. Recently, we found that a nuclear receptor peroxisome proliferator-activated receptor α (PPARα) plays a vital role in induction of a detoxification system by using natural plant seeds as diets for mice [8].

An important role of PPARα in lipid catabolism in the liver has been well established [9], but the PPARα-null mouse shows little phenotypic change when fed with normal laboratory diet [10, 11]. We searched its extrahepatic roles and found that PPARα is essential to induce 17β-hydroxysteroid dehydrogenase type 11 (17βHSD11) in the intestine [12]. Studies on the substrate specificity of 17βHSD11 showed that it includes not only glucocorticoids and sex steroids but also bile acids, fatty acids, and branched amino acids [13, 14]. So we examined the possibility that PPARα plays a vital role in inducing enzymes for metabolizing secondary metabolites of plants by feeding natural plant seeds. We begin this review by summarizing our results of experiments using various plant seeds as diets for wild-type mice and PPARα-null mice. The main focus of this review is on the role of PPARα in inducing a detoxification system against potentially toxic plant compounds.

2. All PPARα-Null Mice Died within 40 Days of Sesame Diet

Sesame is widely thought to be a healthy food and it contains several lignans and lignan glycosides that have antioxidant properties [15, 16]. Thus, our result that feeding the PPARα-null mice with sesame seeds for a short period sometimes caused the death [8] was totally unexpected for us. We first examined whether the lethal effect of feeding sesame to PPARα-null mice was specific to sesame, or whether similar results could be caused by other plant seeds or nuts. For this study, almond (Prunus dulcis) nuts and sunflower (Helianhus annuus) seeds were chosen as control diets on the basis of their lipid contents. All are rich in lipids, but sesame seeds are rich in oleic acid and linoleic acid, whereas almond nuts are rich in oleic acid and sunflower seeds are rich in linoleic acid. Only sesame seeds among the three fatty seeds killed PPARα-null mice in several days. This result suggests that a large amount of major fatty acids itself is not toxic for PPARα-null mice but some sesame-specific or -enriched compounds may be involved in causing a lethal effect in the liver. However, major lignans and lignan glycosides in sesame seeds were not toxic.

Feeding these seeds and nuts induced the formation of lipid droplets with similar fatty acid compositions to those of the diets in the liver of both wild-type and PPARα-null mice [17]. Thus, the fatty acid compositions of neutral lipids in hepatic lipid droplets were strongly influenced by those in the diet, suggesting that the lipid droplets promptly stored the diet-derived excess fats with unfavorable fatty acid compositions and protected the cells from lipotoxicity. No lethal effect of feeding almond nuts or sunflower seeds to PPARα-null mice was observed. The fatty acid compositions of the hepatic lipids quickly returned to normal after changing the diet to the usual one in wild-type mice. This quick reversibility suggests that enhanced lipid metabolism to remodel the fatty acid composition occurred around the lipid droplets in the liver of wild-type mice. However, quick reversibility was not observed in PPARα-null mice. These results suggest that PPARα plays an important role in the rapid induction of lipid-metabolizing/remodeling enzymes according to the contents of the diet [17]. However, PPARα may not be absolutely necessary for metabolism of major fatty acids but vital for detoxification of minor but sesame-enriched abnormal fatty acid(s) or compound(s).

We next examined the survival curve of mice on sesame diet for a long period. Feeding wild-type mice with sesame seed diet had no effect on survival for at least 3 months (not shown) but PPARα-null mice started to die in a few days and all died within 40 days after starting the sesame diet (Figure 1). This drastic effect was age and gender dependent; only male PPARα-null mice of older than 14 weeks of age died on the sesame diet. During these periods, weight gain was not observed in wild-type mice and a gradual weight loss was seen in PPARα-null mice, indicating that living only on sesame seeds is not healthy even for wild-type mice.

Figure 1: Survival curve of normal and PPARα-null mice on sesame diet. Male PPARα-null mice on the sesame diet were followed until all null mice died. None of wild-type mice on the sesame diet or the PPARα-null mice on normal diet died during these period. Time 0 is the day of starting the experiment using age-matched (14 weeks) mice on the sesame diet.

The mechanism for the striking female-specific tolerance to the sesame diet can be similar to that reported by Djouadi et al. [18] for explanation of the result from a carnitine palmitoyltransferase1 (CPT1) inhibitor, etomoxir experiment using PPAR-null mice. Etomoxir treatment killed all male PPAR-null mice almost within 24 h, whereas no female PPAR-null mice nor wild-type mice died within the same period. They did not define the mechanism for the gender-specific response but they speculated that estradiol-triggered fatty acid utilization pathway is important in hepatic lipid and glucose homeostasis. Similar effects of estradiol and also of aging were reported by Duan et al. [19] in the expression of intestinal sterol transporters. Thus, the estradiol-dependent pathway may play an essential role in female-specific tolerance to the sesame diet.

3. The Sesame-Diet-Induced Severe Hypoglycemia in PPARα-Null Mice

Feeding sesame seeds caused a rapid decrease in one day in the serum levels of glucose and in the glycogen contents in the liver of both mice although the reduction in PPARα-null mice was much significant compared with wild-type mice [12]. After the reduction, wild-type mice recovered the serum glucose levels to normal, but the severe hypoglycemia persisted for several days in most PPARα-null mice. Thus, the major cause of the sesame-induced death in PPARα-null mice during a short period would be severe hypoglycemia. There seems to be no possibility that gluconeogenesis was blocked in the PPARα-null mice on a sesame diet at the transcriptional level of the key enzymes in gluconeogenesis. Although feeding sesame seeds differently changed the levels of mRNAs for the key enzymes in gluconeogenesis (phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase), PPARγ-coactivator 1α (PGC-1α), and aquaporins 3 and 9) between wild-type mice and PPARα-null mice, these small changes could not fully explain the sesame-seed-induced persisting hypoglycemia in the PPARα-null mice. Another possibility might be that ATP supply necessary for gluconeogenesis was not enough because mitochondrial function including β-oxidation of fatty acids in the liver was inhibited by some compounds from sesame seeds. The toxic compounds should have been metabolized in a PPARα-dependent manner. In any case, acute hypoglycemia alone cannot explain chronic effect of feeding sesame seeds on PPARα-null mice.

4. The Sesame-Diet-Induced FALDH in the Liver of Normal Mice but Far Less in PPARα-Null Mice

Microarray analysis of PPARα-dependent sesame-induced genes revealed that PPARα plays a vital role in inducing various enzymes for protecting against oxidative stress and xenobiotic metabolism in the intestine and liver [8]. Fatty aldehyde dehydogenase (FALDH or ALDH3A2) was identified as one candidate enzyme induced in the liver for lipid peroxidation [20]. Results from our detailed analyses of the mechanisms for PPARα-dependent transcriptional induction, subcellular localization [21], and protecting against lipotoxicity [22] are summarized in Figure 2. Both polyunsaturated fatty acids and branched fatty acids act as ligands for PPARα and directly regulate expression of FALDH via a direct repeat-1 (DR-1) site located in the promoter region of the FALDH gene. Alternative splicing produces two isoforms, FALDH-N and FALDH-V. FALDH-N localizes on endoplasmic reticulum membrane and detoxifies polyunsaturated fatty-acid-derived fatty aldehydes and protects cells from endoplasmic reticulum stress. FALDH-V is a unique peroxisome-specific aldehyde dehydrogenase playing an essential role in oxidation of branched fatty acids including lipid peroxidation products and phytanic acid from plants.

Figure 2: Proposed physiological role of FALDH. Polyunsaturated fatty acids or branched fatty acids bind to PPARα to express FALDH and FALDH variants produced by alternative splicing share a role in protecting against oxidative stress in an organelle-specific manner.

The expression levels of major endoplasmic localizing FALDH-N and peroxisome-specific FALDH-V in wild-type and PPARα-null mice fed normal or sesame-diet were examined by the real-time PCR analysis using the isoform-specific PCR primers. Both FALDH isoforms were induced several fold from the basal levels by feeding sesame regardless of whether PPARα was expressed or not [21]. This result indicates that expression of FALDH is also regulated by a PPARα-independent mechanism. However, the basal expression levels of both isoforms in PPARα-null mice were quite low and even their induced levels were barely similar with the uninduced levels in wild-type mice. These results suggest that the FALDH activities in the liver of PPARα-null mice were not high enough to protect from the oxidative stress caused by feeding the sesame diet.

5. The Sesame Diet Did Not Cause a Significant Oxidative Stress but Induced Hepatoxicity in PPARα-Null Mice

We next directly examined the possibility that sesame-diet-induced oxidative stress in PPARα-null mice by measuring the serum levels of 8-hydroxy-2′-deoxyguanosine (8OH-dG), an indicator of oxidative damage of DNA [23], and 8-isoprostane, an autooxidation product from arachidonic acid and a biomarker for oxidative stress [24]. The levels of 8OH-dG did not change significantly in wild-type or PPRα-null mice feeding normal or sesame diet. In contrast, the levels of 8-isoprostane in the sera of PPARα-null mice were about 3-fold higher than those of wild-type mice even feeding normal diet (0.3–0.4 versus 0.4–1.4 ng/mL) and the sesame diet did not raise the levels significantly. These results indicate that the sesame diet does not induce a significant oxidative stress and that FALDH may not play an important role in protecting the cells from lipotoxicity induced by the sesame diet. However, they do not exclude a possibility that FALDH is important for metabolism of the sesame-derived toxic compounds.

17βHSD11 was also identified as a sesame-diet-inducible enzyme in a PPARα-dependent manner [8]. 17βHSD11 is mostly localized on the endoplasmic reticulum membrane under normal conditions and redistributes to lipid droplets when their formation is induced by a lipid-rich diet [25, 26]. Its involvement in detoxification of lipophilic toxic compounds compartmentalized in lipid droplets is a plausible possibility. Thus, we think that FALDH and 17βHSD11 are important for detoxification of toxic compounds contained in sesame seeds rather than in protecting the cells from oxidative stress induced by a lipid-rich diet.

To assess liver damage after feeding sesame seeds, we measured the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum of wild-type and PPARα-null mice [8]. Feeding the mice with sesame caused hepatotoxicity as indicated by measuring the plasma alanine transaminase (ALT) activities. At day 3 after starting the diet, ALT activities went up from (IU/L, ±S.D.) to in wild type mice and from toin PPARα null mice, and AST also went up from(IU/L, ±S.D.) toin PPARα null mice. These results suggest that expression of PPARα protected the liver cells from the damages caused by feeding sesame seeds.

6. The Sesame-Diet-Induced Various Cyps in a PPARα-Dependent and a PPARα-Independent Manner

Microarray analysis was performed to identify the sesame-diet-induced detoxification enzymes in the intestine and liver by comparing the expression levels of mRNAs using RNA isolated from wild-type mice and PPARα null mice fed with sesame for one week. Sesame seeds, like other botanicals [27–29], should contain a large number of compounds that affect cell function via gene transcription or metabolic inhibition. In addition to phase II detoxification enzymes such as UDP-glucuronosyltransferases (UGTs), aldoketoreductases (AKRs), glutathione S-transferases (GSTs), and drug transporters [8], the expression levels of several cytochrome P450 enzymes (Cyps) in the intestine and liver were much higher in wild-type mice than in PPARα-null mice when they fed with sesame. These Cyps were induced in a PPARα-dependent manner as confirmed by quantitative real-time PCR analysis although some of them have not been identified as PPARα-target genes. Expressions of the corresponding human CYP2C9, 2B6, and 3A4 to these mouse Cyps were reported be regulated by the constitutive androstane receptor (CAR) [30, 31]. Jackson et al. [32] proposed an imperfect DR4 element as an essential element for CAR-dependent transcriptional activation of Cyp2c29 and 2b10 genes, although no detailed mechanism has yet been elucidated. Thus, the indirect but essential involvement of PPARα in the induction of these Cyps can be at the activation step of CAR. Further analysis is clearly necessary to obtain direct evidence of the involvement of PPARα in the activation step of CAR. Another possibility for the indirect but essential involvement of PPARα in the induction is that some of them are regulated by overlapping transcriptional programs mediated by an axis of PPARα- retinoid X receptor (RXR)and liver X receptor (LXR) as suggested by Anderson et al. [33]. Our observations of indirect but essential involvement of PPARα in the transcriptional activation of several Cyp genes should provide an important clue to elucidate the activation processes and the complex network among the xenobiotic nuclear receptors [34–38].

Microarray analysis and quantitative real-time PCR analysis showed that most detoxification enzyme mRNAs were induced by the sesame diet in both the liver and intestine and the extents of induction were larger in wild-type mice than in PPARα-null mice. However, Cyp2a5 was an exception because it was largely induced by the sesame diet in PPARα-null mice but not all in wild-type mice (unpublished). It is plausible that certain compound(s) in sesame seeds triggered the transcriptional activation of these Cyp genes through an axis of nuclear receptors excluding PPARα. The reason for the PPARα-null mouse-specific induction of some Cyps can be explained by the mechanism that the relevant compounds should have been metabolized to inactive form(s) in the liver of wild-type mice in a PPARα-dependent manner.

7. PPARα as a Member of Transcriptional Regulators for Detoxification of Unfavorable Compounds

In conclusion, the detoxifying enzymes in the liver must be induced by complex functional interactions among xenobiotic receptors, such as CAR, pregnelone X receptor (PXR), and aryl hydrocarbon receptor (AhR), to metabolize a large number of the plant compounds that affect cell function via gene transcription, or metabolic inhibition [8, 39, 40]. As summarized in Figure 3, PPARα should be one of these nuclear receptor. One receptor may be involved in producing the metabolites/ligands for the next receptor that will be involved in inducing the enzymes for further metabolism. Disturbance of this network by genetic mutation, transcriptional repression or metabolic inhibition should severely affect metabolism of xenobiotics if it goes beyond compensating capacity coming from overlapping functions of metabolizing enzymes. PPARα plays wider and more extensive role in energy metabolism form catabolism of endobiotic lipids but also for detoxification of xenobiotic or plant-derived unfavorable compounds than previously thought.

Figure 3: A proposed model depicting the metabolic conversion of plant compounds in animals by the mechanism involving complex network among the xenobiotic nuclear receptors and PPARα.

References

M. E. Fowler, “Plant poisoning in free-living wild animals: a review,” Journal of Wildlife Diseases, vol. 19, no. 1, pp. 34–43, 1983.

J. B. Owens, “Genetic aspects of appetite and food choice in animals,” The Journal of Agricultural Science, vol. 119, no. 2, pp. 151–155, 1992.

D. Y. Mitchell and D. R. Petersen, “Oxidation of aldehydic products of lipid peroxidation by rat liver microsomal aldehyde dehydrogenase,” Archives of Biochemistry and Biophysics, vol. 269, no. 1, pp. 11–17, 1989.

W. B. Rizzo, E. Heinz, M. Simon, and D. A. Craft, “Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjogren-Larsson syndrome,” Biochimica et Biophysica Acta, vol. 1535, no. 1, pp. 1–9, 2000.

M. A. Willemsen, J. J. Rotteveel, J. G. de Jong et al., “Defective metabolism of leukotriene B4 in the Sjogren-Larsson syndrome,” Journal of the Neurological Sciences, vol. 183, no. 1, pp. 61–67, 2001.

T. L. Kelson, S. McVoy Jr., and W. B. Rizzo, “Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization,” Biochimica et Biophysica Acta, vol. 1335, no. 1-2, pp. 99–110, 1997.

G. A. Jansen, D. M. van den Brink, R. Ofman, O. Draghici, G. Dacremont, and R. J. A. Wanders, “Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid α-oxidation pathway is localized in peroxisomes,” Biochemical and Biophysical Research Communications, vol. 283, no. 3, pp. 674–679, 2001.

K. Motojima and T. Hirai, “Peroxisome proliferator-activated receptor α plays a vital role in inducing a detoxification system against plant compounds with crosstalk with other xenobiotic nuclear receptors,” The FEBS Journal, vol. 273, no. 2, pp. 292–300, 2006.

O. Barbier, D. Duran-Sandoval, I. Pineda-Torra, V. Kosykh, J. C. Fruchart, and B. Staels, “The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor α and γ target gene,” Journal of Biological Chemistry, vol. 278, pp. 13975–13983, 2003.

S. S. T. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the α isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995.

S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting,” Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999.

K. Motojima, “17β-hydroxysteroid dehydrogenase type 11 is a major peroxisome proliferator-activated receptor α-regulated gene in mouse intestine,” European Journal of Biochemistry, vol. 271, no. 20, pp. 4141–4146, 2004.

R. Mindnich, G. Moller, and J. Adamski, “The role of 17β-hydroxysteroid dehydrogenases,” Molecular and Cellular Endocrinology, vol. 218, pp. 7–20, 2004.

N. Shafqat, H. U. Marschall, C. Filling et al., “Expanded substrate screenings of human and Drosophila type 10 17 β-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3α/7α/7β/17β/20β/21-HSD,” Biochemical Journal, vol. 376, no. 1, pp. 49–60, 2003.

G. J. Kapadia, M. A. Azuine, H. Tokuda et al., “Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis,” Pharmacological Research, vol. 45, no. 6, pp. 499–505, 2002.

D. Nakano, D. Kurumazuka, Y. Nagai, A. Nishiyama, Y. Kiso, and Y. Matsumura, “Dietary sesamin suppresses aortic NADPH oxidase in DOCA salt hypertensive rats,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 3, pp. 324–326, 2008.

H. Aishan, Y. Horiguchi, and K. Motojima, “Physiologic roles of hepatic lipid droplets and involvement of peroxisome proliferator-activated receptor α in their dynamism,” Biological and Pharmaceutical Bulletin, vol. 33, no. 3, pp. 351–354, 2010.

F. Djouadi, C. J. Weinheimer, J. E. Saffitz et al., “A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice,” Journal of Clinical Investigation, vol. 102, no. 6, pp. 1083–1091, 1998.

L. P. Duan, H. H. Wang, A. Ohashi, and D. Q. H. Wang, “Role ofintestinal sterol transporters Abcg5, and Npc111 in cholesterol absorption in mice: gender and age effects,” American Journal Of Physiology, vol. 290, no. 2, part 1, pp. G269–G276, 2006.

D. Demozay, S. Rocchi, J. C. Mas et al., “Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin,” Journal of Biological Chemistry, vol. 279, no. 8, pp. 6261–6270, 2004.

B. Ashibe, T. Hirai, K. Higashi, K. Sekimizu, and K. Motojima, “Dual subcellular localization in the endoplasmic reticulum and peroxisomes and a vital role in protecting against oxidative stress of fatty aldehyde dehydrogenase are achieved by alternative splicing,” Journal of Biological Chemistry, vol. 282, no. 28, pp. 20763–20773, 2007.

B. Ashibe and K. Motojima, “Fatty aldehyde dehydrogenase is up-regulated by polyunsaturated fatty acid via peroxisome proliferator-activated receptor α and suppresses polyunsaturated fatty acid-induced endoplasmic reticulum stress,” The FEBS Journal, vol. 276, no. 23, pp. 6956–6970, 2009.

A. D. Haegele, S. P. Briggs, and H. J. Thompson, “Antioxidant status and dietary lipid unsaturation modulate oxidative DNA damage,” Free Radical Biology and Medicine, vol. 16, no. 1, pp. 111–115, 1994.

C. Feillet-Coudray, E. Rock, C. Coudray et al., “Lipid peroxidation and antioxidant status in experimental diabetes,” Clinica Chimica Acta, vol. 284, no. 1, pp. 31–43, 1999.

Y. Yokoi, Y. Horiguchi, M. Araki, and K. Motojima, “Regulated expression by PPARα and unique localization of 17β-hydroxysteroid dehydrogenase type 11 protein in mouse intestine and liver,” The FEBS Journal, vol. 274, no. 18, pp. 4837–4847, 2007.

Y. Horiguchi, M. Araki, and K. Motojima, “Identificsation and characterization of the ER/lipid droplet-targeting sequence in 17β-hydroxysteroid dehydrogenase type 11,” Archives of Biochemistry and Biophysics, vol. 479, no. 2, pp. 121–130, 2008.

E. M. van Lieshout, M. M. Bedaf, M. Pieter, C. Ekkel, W. A. Nijhoff, and W. H. Peters, “Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta 1-1 levels,” Carcinogenesis, vol. 19, no. 11, pp. 2055–2057, 1998.

S. Ohno, N. Matsumoto, M. Watanabe, and S. Nakajin, “Flavonoid inhibition of overexpressed human 3β-hydroxysteroid dehydrogenase type II,” Journal of Steroid Biochemistry and Molecular Biology, vol. 88, no. 2, pp. 175–182, 2004.

N. F. Shay and W. J. Banz, “Regulation of gene transcription by botanicals: novel regulatory mechanisms,” Annual Review of Nutrition, vol. 25, pp. 297–315, 2005.

S. S. Ferguson, E. L. Lecluyse, M. Negishi, and J. A. Goldstein, “Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site,” Molecular Pharmacology, vol. 62, no. 3, pp. 737–746, 2002.

J. M. Pascussi, S. Gerbal-Chaloin, L. Drocourt, P. Maurel, and M. J. Vilarem, “The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors,” Biochimica et Biophysica Acta, vol. 1619, no. 3, pp. 243–253, 2003.

J. P. Jackson, S. S. Ferguson, R. Moore, M. Negishi, and J. A. Goldstein, “The constitutive active/androstane receptor regulates phenytoin induction of Cyp2c29,” Molecular Pharmacology, vol. 65, no. 6, pp. 1397–1404, 2004.

S. P. Anderson, C. Dunn, A. Laughter et al., “Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor α, retinoid X receptor, and liver X receptor in mouse liver,” Molecular Pharmacology, vol. 66, no. 6, pp. 1440–1452, 2004.

S. Gerbal-Chaloin, J. M. Pascussi, L. Pichard-Garcia et al., “Induction of CYP2C genes in human hepatocytes in primary culture,” Drug Metabolism and Disposition, vol. 29, no. 3, pp. 242–251, 2001.

D. W. Nebert, T. P. Dalton, A. B. Okey, and F. J. Gonzalez, “Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 23847–23850, 2004.

K. W. Bock and C. Köhle, “Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters,” Drug Metabolism Reviews, vol. 36, no. 3-4, pp. 595–615, 2004.

C. Xu, C. Y. Li, and A. N. Kong, “Induction of phase I, II and III drug metabolism/transport by xenobiotics,” Archives of Pharmacal Research, vol. 28, no. 3, pp. 249–268, 2005.

O. Barbier, C. Fontaine, J. C. Fruchart, and B. Staels, “Genomic and non-genomic interactions of PPARα with xenobiotic-metabolizing enzymes,” Trends in Endocrinology and Metabolism, vol. 15, no. 7, pp. 324–330, 2004.

W. Xie, J. L. Barwick, C. M. Simon et al., “Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR,” Genes and Development, vol. 14, no. 23, pp. 3014–3023, 2000.

K. W. Bock and C. Kohle, “Coodinate regulation of drug metabolism by xenobioticnuclear receptors: UGTs acting together with CYPs and glucronide transporters,” Drug Metabolism Reviews, vol. 36, no. 3-4, pp. 595–615, 2004.